HEPION PHARMACEUTICALS INC (HEPA)
US4268973025 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -48.93M | -42.20M | -32.72M | -20.35M | -6.72M | |||
| Depreciation Amortization | 67.13K | 80.00K | 90.00K | 30.00K | 30.00K | |||
| Income Taxes - Deferred | -409.02K | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | 2.97M | 3.15M | -5.57M | 1.63M | -1.10M | |||
| Interest Paid | 0.00 | 0.00 | 0.00 | 0.00 | 30.00K | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 5.41M | 4.01M | 6.98M | 2.53M | 220.00K | |||
| OPERATING CASH FLOW | -40.89M | -34.96M | -31.22M | -16.17M | -7.57M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -14.30K | -20.00K | -130.00K | -90.00K | -50.00K | |||
| Other Investing Activity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| INVESTING CASH FLOW | -14.30K | -10.00K | -130.00K | -90.00K | -50.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | -180.00K | 180.00K | -1.12M | |||
| Stock Issued/Repurchased | 4.49M | -3.14M | 82.15M | 42.88M | 19.83M | |||
| Other Financing Activity | 0.00 | -2.00M | N/A | N/A | 0.00 | |||
| FINANCING CASH FLOW | 4.49M | -5.14M | 81.98M | 43.05M | 18.71M | |||
| Exchange Rate Effect | 5.02K | -50.00K | N/A | N/A | N/A | |||
| CHANGE IN CASH | -36.40M | -40.16M | 50.63M | 26.79M | 11.09M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -40.89M | -34.96M | -31.22M | -16.17M | -7.57M | |||
| Capital Expenditure | -14.30K | -20.00K | -130.00K | -90.00K | -50.00K | |||
| FREE CASH FLOW | -40.90M | -34.98M | -31.35M | -16.26M | -7.62M | |||
All data in USD